Switch to:
More From Other Websites
The Medicines Co.'s (MDCO) Q2 Earnings Decline Y/Y Jul 24 2014
Medicines (MDCO) is Oversold: Can It Recover? Jul 24 2014
The Medicines Company Reports Second Quarter and First Half 2014 Results Jul 23 2014
Medicines Co Earnings Call scheduled for 8:30 am ET today Jul 23 2014
MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 23 2014
Q2 2014 The Medicines Company Earnings Release - Before Market Open Jul 23 2014
7:01 am The Medicines Co misses by $0.14, reports revs in-line Jul 23 2014
The Medicines Company Reports Second Quarter and First Half 2014 Results Jul 23 2014
The Medicines Company to Announce Second Quarter and First Half 2014 Financial Results on Wednesday,... Jul 09 2014
The Medicines Company to Announce Second Quarter and First Half 2014 Financial Results on Wednesday,... Jul 09 2014
The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the... Jul 07 2014
The Medicines Co. receives market authorization renweal for Angiox Jul 07 2014
The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the... Jul 07 2014
Hyperion's Ravicti Submission Accepted in EU Jun 26 2014
ORBACTIVTM (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine Jun 05 2014
The Medicines Company to Participate in Goldman Sachs 35th Annual Global Healthcare Conference Jun 04 2014
The Medicines Company Presents Seven Hospital Data Analyses at Leading Health Economics and Outcomes... Jun 04 2014
MEDICINES CO /DE Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 30 2014
The Medicines Company to Participate in 2014 Jefferies Global Healthcare Conference May 27 2014
Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published... May 22 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide